AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767E902. A total of 3 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $145,000 | +302.8% | 48,800 | +104.2% | 0.00% | – |
Q2 2016 | $36,000 | -35.7% | 23,900 | +58.3% | 0.00% | -100.0% |
Q1 2016 | $56,000 | -80.4% | 15,100 | -46.6% | 0.00% | -66.7% |
Q4 2015 | $286,000 | -38.6% | 28,300 | -17.5% | 0.00% | -50.0% |
Q3 2015 | $466,000 | +125.1% | 34,300 | +214.7% | 0.01% | +100.0% |
Q2 2015 | $207,000 | -74.7% | 10,900 | -65.1% | 0.00% | -76.9% |
Q1 2015 | $817,000 | +19.3% | 31,200 | -4.6% | 0.01% | +30.0% |
Q4 2014 | $685,000 | -54.4% | 32,700 | -27.3% | 0.01% | -56.5% |
Q3 2014 | $1,502,000 | +38.9% | 45,000 | +33.5% | 0.02% | +35.3% |
Q2 2014 | $1,081,000 | -73.8% | 33,700 | -62.3% | 0.02% | -75.4% |
Q1 2014 | $4,119,000 | -32.7% | 89,300 | +3.5% | 0.07% | -25.0% |
Q4 2013 | $6,124,000 | +12.7% | 86,300 | +36.1% | 0.09% | -11.5% |
Q3 2013 | $5,434,000 | -30.4% | 63,400 | -48.6% | 0.10% | -45.8% |
Q2 2013 | $7,810,000 | – | 123,300 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,700 | $8,664,000 | 0.37% |
GROUP ONE TRADING, L.P. | 33,700 | $1,081,000 | 0.02% |
Citadel Advisors | 47,000 | $1,508,000 | 0.00% |